Cystic fibrosis drug a 'huge moment' for treatment of newborn babies
Siblings Kara and Isaac Moss with their parents Debbie and Wayne Moss, who participated in a landmark study which supports use of a ground-breaking cystic fibrosis drug in infants from four weeks of age. Pictures: Patrick Bolger
A cystic fibrosis (CF) drug that targets the basic defect that causes the condition has been found to be safe and effective for newborn babies aged four weeks and above.
The findings, from new research involving RCSI University of Medicine and Health Sciences and Children's Health Ireland, have been described as "a huge moment" for cystic fibrosis.
